Cardio-Oncology
Cancer therapy may impair cardiorespiratory fitness for years after treatment
Cancer treatment, primarily chemotherapy, is associated with impaired cardiorespiratory fitness years after treatment has ended and regardless of cancer subtype, according to a meta-analysis published in JACC: CardioOncology.
High prevalence of atherosclerosis detected in patients entering lung cancer therapy
CT imaging of patients entering lung cancer treatment identified a high prevalence of atherosclerosis, according to data presented at the American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology Patient course.
SGLT2s could prevent cardiotoxic effects of cancer therapies in patients with diabetes
SGLT2 inhibition may prevent cancer therapy-related cardiac dysfunction and improve other outcomes in patients with diabetes undergoing cancer therapy, researchers reported.
Lung cancer radiotherapy exposes patients to arrhythmia risks based on factors such as dose
Exposure of certain cardiac structures to radiation during treatment of surgically inoperable or unresectable non-small cell lung cancer was associated with increased arrhythmia risk, researchers reported.
Lower socioeconomic status heightens risk for CVD death among cancer survivors
Cancer survivors with the lowest socioeconomic status appeared twice as likely to die of CVD than those with the highest household incomes, according to a study published in European Heart Journal – Quality of Care and Clinical Outcomes.
Air pollution linked to heart disease, cancer risk, likely via shared risk factors
Air pollution exposure may contribute to both CV and cancer risk by interacting with various common risk factors such as inflammation, oxidative stress and epigenetic modifications, according to a state-of-the-art review.
Enalapril does not prevent chemotherapy-related heart damage in breast cancer, lymphoma
ATLANTA — Enalapril plus standard care was not superior to standard care alone for preventing cardiotoxicity in patients receiving treatment for breast cancer or lymphoma, according to new data from the PROACT trial.
Sleep apnea an early predictor of cancer therapy-related heart failure
Sleep apnea could be an early indicator of cancer therapy-related cardiomyopathy, according to new data presented at the American College of Cardiology Advancing the Cardiovascular Care of the Oncology Patient course.
Heart failure specialist to lead NYU Langone Health’s cardio-oncology program
Michelle Bloom, MD, has been named system director of the cardio-oncology program at NYU Langone Health.
Physical and mental health measures worse for adults with HF vs. lung, colorectal cancers
PHILADELPHIA — Older adults with heart failure have worse physical and mental health than those with several types of cancer, a speaker reported at the American Heart Association Scientific Sessions.